Advances in nuclear medicine-based molecular imaging in head and neck squamous cell carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in nuclear medicine-based molecular imaging in head and neck squamous cell carcinoma
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-12
DOI
10.1186/s12967-022-03559-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nivolumab-DTPA-Based PD-1 Imaging Reveals Structural and Pathological Changes in Colorectal Carcinoma
- (2022) Danni Li et al. Frontiers in Bioengineering and Biotechnology
- Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
- (2022) Mohammad Javed Ansari et al. Cell Communication and Signaling
- Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
- (2021) Matt Lechner et al. Nature Communications
- A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study
- (2021) Chunxia Qin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Clinical utility of [68Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma
- (2021) Liang Zhao et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
- (2021) Yuheng Hu et al. Frontiers in Endocrinology
- Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity – initial experience and comparison to [18F]FDG PET/CT and MRI
- (2021) Christian Linz et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Somatostatin receptor imaging with [68Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinoma
- (2021) Liang Zhao et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus–associated nasopharyngeal carcinoma
- (2021) Kartik Viswanathan et al. HUMAN PATHOLOGY
- ImmunoPET: Concept, Design, and Applications
- (2020) Weijun Wei et al. CHEMICAL REVIEWS
- Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT
- (2020) D. Lobeek et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer
- (2020) Haojun Chen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
- (2020) M. Syed et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Head and neck tumors angiogenesis imaging with 68Ga-NODAGA-RGD in comparison to 18F-FDG PET/CT: a pilot study
- (2020) Steve Durante et al. EJNMMI Research
- Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings
- (2020) Haojun Chen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Improved cancer detection in Waldeyer’s tonsillar ring by 68Ga-FAPI PET/CT imaging
- (2020) S. Serfling et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers
- (2020) Sanjana Ballal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Head and neck squamous cell carcinoma
- (2020) Daniel E. Johnson et al. Nature Reviews Disease Primers
- 89Zr-DFO-Cetuximab as a Molecular Imaging Agent to Identify Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma
- (2019) Raquel Benedetto et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review
- (2019) Barbora Peltanova et al. Molecular Cancer
- Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial
- (2019) Douglas Adkins et al. LANCET ONCOLOGY
- Metastatic Nasopharyngeal Carcinoma Treated With Intraarterial Combined With Intravenous Peptide Receptor Radionuclide Therapy
- (2019) Wenjia Zhu et al. CLINICAL NUCLEAR MEDICINE
- Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling
- (2018) Debanjan Dhar et al. CANCER CELL
- 68Ga-DOTATATE PET/CT Reveals Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma in a Case of Suspected Sphenoid Wing Meningioma
- (2018) Marcus Unterrainer et al. CLINICAL NUCLEAR MEDICINE
- Immuno-PET Imaging of 89Zr Labeled Anti-PD-L1 Domain Antibody
- (2018) Dan Li et al. MOLECULAR PHARMACEUTICS
- What about α v β 3 integrins in molecular imaging in oncology?
- (2018) Frederic Debordeaux et al. NUCLEAR MEDICINE AND BIOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular imaging to enlighten cancer immunotherapies and underlying involved processes
- (2018) Elly L. van der Veen et al. CANCER TREATMENT REVIEWS
- FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers
- (2018) Frederik Giesel et al. JOURNAL OF NUCLEAR MEDICINE
- Preliminary application of 125I–nivolumab to detect PD-1 expression in colon cancer via SPECT
- (2018) Danni Li et al. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
- Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma
- (2018) Julia Odenthal et al. Scientific Reports
- Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
- (2018) Ezra E W Cohen et al. LANCET
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
- (2018) Frederike Bensch et al. NATURE MEDICINE
- Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC
- (2018) Lillian L. Siu et al. JAMA Oncology
- 89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer
- (2017) Christopher G. England et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Current status of theranostics in prostate cancer
- (2017) Irene Virgolini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Detection of Synchronous Primary Malignancies with68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients
- (2017) Medhat M. Osman et al. JOURNAL OF NUCLEAR MEDICINE
- PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer
- (2017) Judith van Loon et al. RADIOTHERAPY AND ONCOLOGY
- Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model
- (2017) In Ho Song et al. Oncotarget
- Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma
- (2017) Ayman Oweida et al. OncoImmunology
- Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma
- (2017) Masahiro Kikuchi et al. OncoImmunology
- RGD-Binding Integrins in Head and Neck Cancers
- (2017) Hanadi Ahmedah et al. Cancers
- Exploring the Role of RGD-Recognizing Integrins in Cancer
- (2017) Markus Nieberler et al. Cancers
- Tumor microenvironment and cancer therapy resistance
- (2016) Yu Sun CANCER LETTERS
- RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study
- (2016) Shih-Hsin Chen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors
- (2016) Ryan Gentzler et al. Immunotherapy
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
- (2016) Tanguy Y Seiwert et al. LANCET ONCOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
- (2016) Aniek J.G. Even et al. Oncotarget
- PET of EGFR with64Cu-cetuximab-F(ab′)2in mice with head and neck squamous cell carcinoma xenografts
- (2015) Laura K. van Dijk et al. Contrast Media & Molecular Imaging
- Correlation between 68Ga-DOTA-NOC PET/CT and 18F-FDG PET/CT in EBV-positive undifferentiated nasopharyngeal carcinoma
- (2015) Lih Kin Khor et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma
- (2015) Lih Kin Khor et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma
- (2015) ANNA-KARIN HAYLOCK et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Fibroblast activation protein α in tumor microenvironment: Recent progression and implications (Review)
- (2015) FUMING ZI et al. Molecular Medicine Reports
- Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging
- (2015) Roy L. Maute et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors
- (2015) Neeta Pandit-Taskar et al. EJNMMI Research
- 68Ga-DOTA0-Tyr3-octreotide positron emission tomography in nasopharyngeal carcinoma
- (2014) Volker H. Schartinger et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)
- (2014) Koen Jansen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy
- (2014) Elizabeth J. Hamson et al. Proteomics Clinical Applications
- Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
- (2014) Joseph M. Curry et al. SEMINARS IN ONCOLOGY
- In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study
- (2014) Anna-Karin Haylock et al. EJNMMI Research
- 68Ga-DOTA0-Tyr3-octreotide positron emission tomography in head and neck squamous cell carcinoma
- (2013) Volker H. Schartinger et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Somatostatin receptors: From signaling to clinical practice
- (2013) Marily Theodoropoulou et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- 111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts
- (2013) Laura K. van Dijk et al. RADIOTHERAPY AND ONCOLOGY
- Neuroendocrine differentiation in head and neck squamous cell carcinoma
- (2012) V H Schartinger et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity
- (2012) Michael C Haffner et al. MODERN PATHOLOGY
- Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells
- (2011) H. Xu et al. CLINICAL CANCER RESEARCH
- An Unusual Case of Positive Somatostatin Receptor Scintigraphy in Squamous Cell Carcinoma of Head and Neck
- (2011) John T. Doan et al. CLINICAL NUCLEAR MEDICINE
- PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model
- (2011) Weihua Li et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Molecular imaging and targeted therapies
- (2010) David L. Morse et al. BIOCHEMICAL PHARMACOLOGY
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
- (2010) Bianca A.W. Hoeben et al. INTERNATIONAL JOURNAL OF CANCER
- Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas
- (2010) EVA-MARIA FABRICIUS et al. Experimental and Therapeutic Medicine
- Somatostatin Receptor Scintigraphy in Nasopharyngeal Carcinoma
- (2009) Roelof J. Bennink et al. CLINICAL NUCLEAR MEDICINE
- Targeted therapy in head and neck cancer
- (2008) Corey J. Langer CANCER
- Imaging in the era of molecular oncology
- (2008) Ralph Weissleder et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started